查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美家禽疫苗市場預測至 2031 年 - 區域分析 - 按類型、技術、劑型、疾病、給藥途徑和最終用戶
市場調查報告書
商品編碼
1597053

北美家禽疫苗市場預測至 2031 年 - 區域分析 - 按類型、技術、劑型、疾病、給藥途徑和最終用戶

North America Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User
出版日期: | 出版商: The Insight Partners | 英文 117 Pages | 訂單完成後即時交付

價格

2023年北美家禽疫苗市值為7.0204億美元，預計到2031年將達到13.2726億美元；預計2023年至2031年複合年成長率為8.3%。

家禽疾病盛行率上升推動北美家禽疫苗市場

家禽生產透過雞蛋和肉類生產不同類型的動物蛋白質。隨著家禽產量的增加，人們很容易感染「禽病」等幾種人畜共通傳染病，這可能會導致巨大的經濟損失，特別是在發展中國家。例如，雞更容易受到細菌、病毒、寄生蟲和真菌感染。這些病毒爆發可引起新城疫、禽流感、傳染性法氏囊病和其他家禽動物的其他疾病。

下表提供了 2022 年加拿大各地哺乳動物禽流感疫情的情況。

哺乳動物感染禽流感病例

國家

家禽疾病

疾病爆發 (2022)

加拿大

40

加拿大

H5N5

2

資料來源：世界動物衛生組織 2023

家禽疾病是雛雞死亡的主要原因，也導致雞隻的牲畜生產力下降。由於農民傳播人畜共通傳染病，給哺乳動物帶來嚴重的健康風險，他們在全球範圍內面臨巨大的經濟損失。例如，家禽球蟲病是全球最常見的疾病之一；它導致與死亡率、體重減輕以及與預防和治療控制相關的額外費用相關的巨大損失。根據帝斯曼網站的數據，全球範圍內的雞和禽類球蟲病導致農民每年面臨 30 億美元的經濟損失。新城疫也被認為是一種經濟代價高昂的疾病，對出口家禽產品的發展中國家的農民造成巨大的生產損失。

因此，家禽疾病流行率的上升造成巨大的經濟損失，增加了家禽疫苗接種的需求，從而帶動了市場。

北美洲家禽疫苗市場概況

北美佔據家禽疫苗市場的主要佔有率。在北美區域市場中，美國佔據最大佔有率，因為該國擁有頂級公司和完善的疫苗接種服務中心。上述事實是預測期內影響該地區市場成長的關鍵因素之一。

北美家禽疫苗市場收入及 2031 年預測（百萬美元）

北美家禽疫苗市場細分

北美家禽疫苗市場按類型、技術、劑型、疾病、給藥途徑、最終用戶和國家分類。

根據類型，北美家禽疫苗市場分為肉雞和蛋雞。 2023 年，肉雞細分市場將佔據更大的市場佔有率。

從技術上來看，北美家禽疫苗市場分為減毒活疫苗、去活化疫苗和重組疫苗。減毒活疫苗細分市場在 2023 年佔據最大的市場。

以劑型分類，北美家禽疫苗市場分為液體疫苗、冷凍乾燥疫苗和粉狀/粉狀疫苗。 2023 年，液體疫苗領域佔據最大的市場。

根據疾病，北美家禽疫苗市場分為禽流感、傳染性支氣管炎、馬立克氏症、禽沙門氏菌病、傳染性法氏囊病（IBD）、新城疫等。 2023 年，禽流感細分市場佔最大市場。

從給藥途徑來看，北美家禽疫苗市場分為飲用水（D/W）、肌肉（I/M）、皮下（I/S）等。 2023 年，飲用水 (D/W) 領域佔據最大的市場佔有率。

根據最終用戶，北美家禽疫苗市場分為家禽養殖場和孵化場、獸醫院以及家禽疫苗接種中心和診所。 2023 年，家禽養殖場和孵化場領域佔據最大的市場佔有率。

按國家/地區分類，北美家禽疫苗市場分為美國、加拿大和墨西哥。 2023年，美國在北美家禽疫苗市場佔有率中佔據主導地位。

Starkey Laboratories Inc.、Audina Hearing Instruments Inc.、Sebotek Hearing Systems LLC、Earlens Corp、GN Store Nord AS、Cochlear Ltd、WS Audiology AS、Sonova Holding AG、Sonic Innovations Inc 和 Amplifon Hearing Health Care Corp. 是一些領先的公司在北美家禽疫苗市場營運的公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

第 4 章：北美家禽疫苗市場 - 主要市場動態

  • 市場促進因素
    • 家禽疾病盛行率上升
    • 不斷發展的家禽業
  • 市場限制
    • 疫苗接種失敗和處理不當
  • 市場機會
    • 政府對大規模疫苗接種活動和創新計畫的支持
  • 未來趨勢
    • 載體疫苗和聯合疫苗的進展
  • 促進因素和限制的影響：

第 5 章：北美家禽疫苗市場分析

  • 2023-2031年家禽疫苗市場收入

第 6 章：北美家禽疫苗市場分析 - 按類型

  • 概述
  • 肉雞
  • 層

第 7 章：北美家禽疫苗市場分析 - 依技術

  • 概述
  • 減毒活疫苗
  • 去活化疫苗
  • 重組疫苗

第 8 章：北美家禽疫苗市場分析 - 按劑型

  • 概述
  • 液體疫苗
  • 凍乾疫苗
  • 粉狀/粉狀疫苗

第 9 章：北美家禽疫苗市場分析 - 按疾病

  • 概述
  • 禽流感
  • 沙門氏菌病
  • 馬立克氏症
  • 傳染性支氣管炎 (IB)
  • 傳染性法氏囊病 (IBD)
  • 新城疫
  • 其他

第 10 章：北美家禽疫苗市場分析 - 按給藥途徑

  • 概述
  • 飲用水（乾/乾）
  • 肌肉注射 (I/M)
  • 皮下注射（S/C）
  • 其他

第 11 章：北美家禽疫苗市場分析 - 按最終用戶

  • 概述
  • 家禽養殖場
  • 獸醫院
  • 家禽疫苗接種中心和診所

第 12 章：北美家禽疫苗市場 - 國家分析

  • 北美市場概況
    • 美國
    • 加拿大
    • 墨西哥

第 13 章：產業格局

  • 概述
  • 家禽疫苗市場的成長策略
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 14 章：公司簡介

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Phibro Animal Health Corp
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc
  • Merck KGaA
  • Ceva
  • Vaccinova AB

第 15 章：附錄

Product Code: TIPRE00023751

The North America poultry vaccines market was valued at US$ 702.04 million in 2023 and is expected to reach US$ 1,327.26 million by 2031; it is estimated to record a CAGR of 8.3% from 2023 to 2031.

Rising Prevalence of Poultry Diseases Fuels North America Poultry Vaccines Market

Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as "Fowl disease" that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle Disease, Avian Influenza, Infectious Bursal Disease, and other diseases in other poultry animals.

Poultry diseases are a major cause of death of chicks and also lead to reduced livestock productivity of chickens. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products.

Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.

North America Poultry Vaccines Market Overview

North America accounts major share for poultry vaccines market. Among the North America regional market, US accounts maximum share due to presence of top companies in the country and well-established centers providing vaccination services. Such aforementioned facts are one of the key factors that influence market growth in the region for the forecast period.

North America Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

North America Poultry Vaccines Market Segmentation

The North America poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the North America poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the North America poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the North America poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the North America poultry vaccines market is segmented into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the North America poultry vaccines market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the North America poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the North America poultry vaccines market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry vaccines market share in 2023.

Starkey Laboratories Inc., Audina Hearing Instruments Inc, Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, and Amplifon Hearing Health Care Corp. are some of the leading companies operating in the North America poultry vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

4. North America Poultry Vaccines Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Poultry Diseases
    • 4.1.2 Growing Poultry Industry
  • 4.2 Market Restraints
    • 4.2.1 Vaccination Failure and Improper Handling
  • 4.3 Market Opportunities
    • 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
  • 4.4 Future Trends
    • 4.4.1 Advancements in Vectored and Combination Vaccines
  • 4.5 Impact of Drivers and Restraints:

5. North America Poultry Vaccines Market Analysis

  • 5.1 Poultry Vaccines Market Revenue (US$ Million), 2023-2031

6. North America Poultry Vaccines Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Broiler
    • 6.2.1 Overview
    • 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Layer
    • 6.3.1 Overview
    • 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Poultry Vaccines Market Analysis - by Technology

  • 7.1 Overview
  • 7.2 Live Attenuated Vaccines
    • 7.2.1 Overview
    • 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Inactivated Vaccines
    • 7.3.1 Overview
    • 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Recombinant Vaccines
    • 7.4.1 Overview
    • 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Poultry Vaccines Market Analysis - by Dosage Form

  • 8.1 Overview
  • 8.2 Liquid Vaccines
    • 8.2.1 Overview
    • 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Freeze-Dried Vaccines
    • 8.3.1 Overview
    • 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Dust/Powdered Vaccines
    • 8.4.1 Overview
    • 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Poultry Vaccines Market Analysis - by Disease

  • 9.1 Overview
  • 9.2 Avian Influenza
    • 9.2.1 Overview
    • 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Salmonellosis
    • 9.3.1 Overview
    • 9.3.2 Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Marek's Disease
    • 9.4.1 Overview
    • 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Infectious Bronchitis (IB)
    • 9.5.1 Overview
    • 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Infectious Bursal Disease (IBD)
    • 9.6.1 Overview
    • 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Newcastle Disease
    • 9.7.1 Overview
    • 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Poultry Vaccines Market Analysis - by Route of Administration

  • 10.1 Overview
  • 10.2 Drinking Water (D/W)
    • 10.2.1 Overview
    • 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Intramuscular (I/M)
    • 10.3.1 Overview
    • 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Subcutaneous (S/C)
    • 10.4.1 Overview
    • 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Poultry Vaccines Market Analysis - by End User

  • 11.1 Overview
  • 11.2 Poultry Farms
    • 11.2.1 Overview
    • 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Veterinary Hospitals
    • 11.3.1 Overview
    • 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Poultry Vaccination Centers and Clinics
    • 11.4.1 Overview
    • 11.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. North America Poultry Vaccines Market - Country Analysis

  • 12.1 North America Market Overview
    • 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
      • 12.1.1.1 United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Overview
        • 12.1.1.1.2 United States: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.1.3 United States: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.1.5 United States: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
        • 12.1.1.1.7 United States: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.2 Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 Overview
        • 12.1.1.2.2 Canada: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
        • 12.1.1.2.7 Canada: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.3 Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Overview
        • 12.1.1.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
        • 12.1.1.3.7 Mexico: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Poultry Vaccines Market
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.1 Inorganic Developments
    • 13.1.1 Overview

14. Company Profiles

  • 14.1 Boehringer Ingelheim International GmbH
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Zoetis Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Phibro Animal Health Corp
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Dechra Pharmaceuticals PLC
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Elanco Animal Health Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Ceva
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Vaccinova AB
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Poultry Vaccines Market Segmentation
  • Table 2. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 3. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 5. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 6. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 7. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 8. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 10. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 11. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 12. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 13. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 15. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 16. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 17. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 18. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
  • Table 19. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 20. Organic Developments Done by Companies
  • Table 21. Inorganic Developments Done by Companies
  • Table 22. Glossary of Terms, Vaccine Adjuvants Market

List Of Figures

  • Figure 1. North America Poultry Vaccines Market Segmentation, by Country
  • Figure 2. Poultry Vaccines Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2023-2031
  • Figure 5. Poultry Vaccines Market Share (%) - by Type, 2023 and 2031
  • Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Poultry Vaccines Market Share (%) - by Technology, 2023 and 2031
  • Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Poultry Vaccines Market Share (%) - by Dosage Form, 2023 and 2031
  • Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Poultry Vaccines Market Share (%) - by Disease, 2023 and 2031
  • Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Marek's Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Poultry Vaccines Market Share (%) - by Route of Administration, 2023 and 2031
  • Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Poultry Vaccines Market Share (%) - by End User, 2023 and 2031
  • Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Poultry Vaccination Centers and Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. North America: Poultry Vaccines Market by Key Countries - Revenue (2023) US$ Million
  • Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 35. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 36. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 37. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 38. Growth Strategies in the Poultry Vaccines Market